Abingworth
abingworth.com Direct investor
Early-stage life science and biopharma venture capital firm with 50+ years of investing in biotechnology. Manages 15 life science funds focused on transformative healthcare solutions.
Abingworth is a venture capital firm headquartered in London, United Kingdom, founded in 1973. It invests directly in companies, from seed to Series C and later, in life sciences, biotechnology and pharmaceuticals. Its stated cheque size is $15-$30m In total per company. 200 portfolio companies, as it reports.
“Working with entrepreneurs to turn breakthrough science into breakthrough medicine”
— Abingworth, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- London, United Kingdom
- Invests in
- GB, US, EU
- Sectors
- life sciences, biotechnology, pharmaceuticals
- Cheque size
- $15-$30m In total per company
- Founded
- 1973
- Portfolio
- 200 companies
Team, as Abingworth publishes it
- Bali Muralidhar Global Head of Life Sciences & CIO
- Kurt von Emster Managing Partner
- Jayson Punwani Managing Director, Head of Venture
- Andrew Sinclair Managing Director, Head of Publics & Late Stage
- Robert DeBenedetto Managing Director, CCD
- Travis Wilson Managing Director, CCD
- Tim Haines Executive Partner
- Vincent Miles Executive Director
- Ron Hsu Principal
- Diya Malhotra Principal
- Graham Mills Principal
- Ankur Shah Vice President, CCD
Names and roles exactly as listed on abingworth.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 167 co-investors found.
- SV Health Investors 1 shared company: ethercreative.co.uk
- Abac Capital 1 shared company: goo.gl
- AC Ventures 1 shared company: goo.gl
- Acrewood Holdings 1 shared company: goo.gl
- Adara Ventures 1 shared company: goo.gl
- Adit Ventures Management, LLC 1 shared company: goo.gl
- AE Industrial Partners, LP 1 shared company: goo.gl
- AIF Capital 1 shared company: goo.gl
- Alchemy Special Opportunities LLP 1 shared company: goo.gl
- Alcuin Capital Partners LLP 1 shared company: goo.gl
and 157 more — the graph.
Where this comes from
Every fact above was read from a page Abingworth publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- http://www.abingworth.com/thesis_quote, sectors, portfolio_count, stage_min, stage_max
- http://www.abingworth.com/portfolioportfolio_count
- https://wikidata.org/wiki/Q28457756founded, hq_city, hq_country
- https://www.abingworth.com/name, is_investor, type, hq_country, hq_city, description, founded, status, confidence
- https://www.abingworth.com/strategylayer, invests_in_geographies, stage_min, stage_max, sectors, cheque_size, thesis_quote, thesis_quote_page
- https://www.abingworth.com/aboutportfolio_count
- https://www.abingworth.com/teampeople
- https://www.wikidata.org/wiki/Q28457756founded, hq_country
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 43 · added 2026-08-27 · link last verified 2026-09-06 · confidence high
Similar investors
- Epidarex CapitalVenture capital · Seed – Series A · Edinburgh, United Kingdom
- Monograph Capital Advisors (UK) LLPVenture capital · Seed – Series B · London, United Kingdom
- Advent Life Sciences LLPVenture capital · Seed – Series B · London, United Kingdom
- Calculus CapitalVenture capital · Seed – Growth · London, United Kingdom
- Parkwalk AdvisorsVenture capital · Seed – Series C+ · London, United Kingdom
- 2150Venture capital · London, United Kingdom